Overview of Wegovy

Monthly Searches

550,000

Competition

HIGH

Interest Over Past 5 Years

67,300,000.00%

Interest Over Past 12 Months

-32.70%

Monthly searches for last 5 years

Monthly searches for last 12 months

What is "Wegovy"?

Wegovy is a prescription medication for adults with obesity or overweight. It contains semaglutide and works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food. It is used as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management. Patients taking Wegovy lost an average of 35 lbs over 68 weeks, and 83% of them lost 5% or more of their weight. Wegovy comes in 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg pens, while Ozempic is available in 0.25 mg, 0.5 mg, and 1.0 mg pens. It may take several weeks or months before a person notices weight loss or a decrease in appetite from Wegovy.

RamenApps Analysis

Wegovy is a prescription medication that has recently seen a surge in relative interest over time, with a peak interest of 96 in March 2023. This medication is used for chronic weight management and has shown promising results, with patients losing an average of 35 lbs over 68 weeks. The associated search terms suggest that people are looking for information around the side effects, cost, dosing, and weight loss results of Wegovy. Additionally, there is growing interest in related medications such as Semaglutide and Ozempic, as well as weight loss injections and anti-obesity medication. These trends suggest that there is a growing demand for effective and safe weight loss solutions, and Wegovy is positioned to meet that demand. The projected future of Wegovy looks promising, and as more people become aware of its benefits, it is likely to see continued growth and interest.